STING1 and metabolic dysfunction-associated steatotic liver disease: First, we focused on the variations in the intestinal microbiota after the change in the genotype and their impact on the occurrence and development of NAFLD; the specific mechanism of STING promoting the evolution of NAFLD disease is still not clear.